Literature DB >> 21681366

[Quantification of fluorescein angiography in patients with non-arteritic anterior ischemic optic neuropathy].

T Hirsch1, A Remky, N Plange, M Kaup.   

Abstract

PURPOSE: The aim of this study was to evaluate the retinal hemodynamics and optic disc leakage by fluorescein angiography in patients with non-arteritic anterior ischemic optic neuropathy (NAION) and to correlate fluorescein angiography findings with the extent and topography of visual field loss.
METHODS: A total of 26 patients with acute NAION were included in the study. Fluorescein angiograms were performed by means of a scanning laser ophthalmoscope. The extent of early-phase optic disc leakage was assessed using a semiquantitative approach (focal versus diffuse type of leakage). Retinal arteriovenous passage (AVP) times were measured using dye dilution curves and digital image analysis for each hemisphere. The number of defective visual field points (StatPac: p<0.5%, uncorrected deviation plot) were evaluated (30/2 SITA, Humphrey-Zeiss) for the hemifields and different sectors.
RESULTS: In this study of patients with NAION the mean AVP was 1.79 s±0.43 which was not significantly correlated to the number of defective points. Furthermore, AVP was not significantly different in focal versus diffuse optic disc leakage. The number of defective points were not significantly different in focal versus diffuse leakage of the optic disc (p=0.57).
CONCLUSION: Retinal perfusion is not linked to the type and topography of disc leakage or the extent and topography of visual field damage in NAION. A global circulatory disorder e.g. due to a compartment syndrome of the optic nerve might account for these results.

Entities:  

Mesh:

Year:  2011        PMID: 21681366     DOI: 10.1007/s00347-011-2387-9

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  20 in total

1.  Video fluorescein angiography: method and clinical application.

Authors:  S Wolf; F Jung; H Kiesewetter; N Körber; M Reim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

2.  Anterior ischaemic optic neuropathy. I. Terminology and pathogenesis.

Authors:  S S Hayreh
Journal:  Br J Ophthalmol       Date:  1974-12       Impact factor: 4.638

3.  Colour and fluorescence of the optic disc.

Authors:  S S Hayreh
Journal:  Ophthalmologica       Date:  1972       Impact factor: 3.250

4.  Optic disk size in ischemic optic neuropathy.

Authors:  A M Mansour; D Shoch; S Logani
Journal:  Am J Ophthalmol       Date:  1988-11-15       Impact factor: 5.258

5.  Nonarteritic ischemic optic neuropathy. The impact of tobacco use.

Authors:  S M Chung; C A Gay; J A McCrary
Journal:  Ophthalmology       Date:  1994-04       Impact factor: 12.079

6.  Color Doppler velocimetry of the optic nerve head in arterial occlusion.

Authors:  T H Williamson; G M Baxter; G N Dutton
Journal:  Ophthalmology       Date:  1993-03       Impact factor: 12.079

7.  Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients.

Authors:  Vincent A Deramo; Robert C Sergott; James J Augsburger; Rod Foroozan; Peter J Savino; Anthony Leone
Journal:  Ophthalmology       Date:  2003-05       Impact factor: 12.079

8.  Fundus lesions in malignant hypertension. V. Hypertensive optic neuropathy.

Authors:  S S Hayreh; G E Servais; P S Virdi
Journal:  Ophthalmology       Date:  1986-01       Impact factor: 12.079

9.  The morphology of an infarct in nonarteritic anterior ischemic optic neuropathy.

Authors:  Rachel A Tesser; Eric R Niendorf; Leonard A Levin
Journal:  Ophthalmology       Date:  2003-10       Impact factor: 12.079

10.  Ischemic optic neuropathy.

Authors:  S S Hayreh
Journal:  Int Ophthalmol       Date:  1978-09       Impact factor: 2.031

View more
  1 in total

1.  Analysis of Macular Microperimetry Characteristics in Non-Arteritic Anterior Ischemic Optic Neuropathy.

Authors:  Hongxia Gong; Huilan Wang; Nan Zhou
Journal:  Med Sci Monit       Date:  2020-11-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.